Hello, everyone, and how are you today? We are doing just fine, thank you, despite the hazy skies and muggy temperatures enveloping the Pharmalot campus. Our solution is to cool off with a hot cup of stimulation. This might sound counter-intuitive, but see what happens and report back to us. What have you got to lose? Meanwhile, here are a few tidbits to get you started on your journey today. We hope all goes well, despite the tumult outside your door. Stay in touch and stay safe. …

Drug makers racing to develop Covid-19 vaccines are already working behind the scenes to build the supply chains needed to deliver their drugs to billions of people as rapidly as possible, The Wall Street Journal says. To serve global demand once a vaccine is approved, a complicated and high-stakes supply chain would kick into gear on a scale that the drug industry has rarely seen. The preparations involve lining up raw materials and factory capacity to manufacture a vaccine in large volumes, and equipment needed to transport many millions of doses at once through distribution channels that will be subject to tight security and temperature controls.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy